Antioxidative strategy for inflammatory diseases
Journal
Mediators of Inflammation
Journal Volume
2015
Pages
675816
Date Issued
2015
Author(s)
Abstract
Cellular oxidants are unique classes of signaling messengers, those control signal transduction events to drive desirable cellular and biological responses, such as inflammatory cytokine production [1, 2]. However, imbalance oxidative stress causes both cellular damage and biological damage. Thus, it is reasonable to counter balance of oxidative stress to treat inflammation-related diseases by modulating reactive oxygen species (ROS) production. Such antioxidative therapeutic strategies include various endogenous and exogenous antioxidative enzymes, antioxidants, and radical scavengers [3].
Other Subjects
antioxidant; ascorbic acid; copper zinc superoxide dismutase; free radical; glutathione; glutathione peroxidase; reactive oxygen metabolite; antioxidant; reactive oxygen metabolite; clinical trial (topic); diabetes mellitus; Editorial; human; inflammatory disease; oxidative stress; priority journal; systemic sclerosis; animal; metabolism; oxidation reduction reaction; Animals; Antioxidants; Humans; Oxidation-Reduction; Reactive Oxygen Species
Publisher
Hindawi Publishing Corporation
Type
editorial